A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

February 21, 2018

Primary Completion Date

August 14, 2018

Study Completion Date

September 21, 2018

Conditions

Healthy Volunteers

Interventions

DRUG

Vedolizumab SC

Vedolizumab SC liquid.

Trial Locations (1)

Celerion, Tempe